Cadwalader Advises Corindus Vascular Robotics on Acquisition by Siemens Healthineers AG
October 31, 2019
October 31, 2019
NEW YORK, Oct. 31 -- Cadwalader, Wickersham and Taft, a financial services law firm, issued the following news release:
Cadwalader advised Corindus Vascular Robotics, Inc. (NYSE American: CVRS) on its acquisition by a subsidiary of Siemens Healthineers AG in a transaction valued at $1.1 billion.
Corindus Vascular Robotics, Inc. is a global technology leader in robotic-assisted vascular interventions. The Company's CorPath(R) platform is the first FDA-cleared medical dev . . .
Cadwalader advised Corindus Vascular Robotics, Inc. (NYSE American: CVRS) on its acquisition by a subsidiary of Siemens Healthineers AG in a transaction valued at $1.1 billion.
Corindus Vascular Robotics, Inc. is a global technology leader in robotic-assisted vascular interventions. The Company's CorPath(R) platform is the first FDA-cleared medical dev . . .